Containing the costs of antibacterial therapy Tracey Langsdale Newsletter Article 17 February 2013 Pages: 3 - 4
Don’t waste healthcare resources on treating acute bronchiolitis Newsletter Article 17 February 2013 Pages: 4 - 4
Role for TDM in cost-effective anticonvulsant therapy Newsletter Article 17 February 2013 Pages: 5 - 5
Insulin pump reduces costs of poorly-controlled diabetes Newsletter Article 17 February 2013 Pages: 6 - 6
Determining the cost effectiveness of hepatitis A prevention strategies Newsletter Article 17 February 2013 Pages: 7 - 7
Aciclovir cost effective for shingles, but not for chickenpox Newsletter Article 17 February 2013 Pages: 7 - 7
Pharmacist’s role in antimicrobial cost containment Newsletter Article 17 February 2013 Pages: 10 - 10
Is adding ramipril to conventional CHF therapy cost effective? Newsletter Article 17 February 2013 Pages: 11 - 11
Look beyond drug acquisition costs when treating serious infection Newsletter Article 17 February 2013 Pages: 12 - 12
Bacteriuria screening and treatment ‘cost beneficial’ during pregnancy Newsletter Article 17 February 2013 Pages: 13 - 13
Economic/clinical analyses in parallel - how to overcome the problems Newsletter Article 17 February 2013 Pages: 14 - 14